期刊文献+

雷氏丹参片治疗冠心病心绞痛的临床疗效分析 被引量:6

Clinical observation on effect of Lei's Danshen Tablets in treating patients with angina pectoris
在线阅读 下载PDF
导出
摘要 目的:研究丹参片治疗冠心病心绞痛的临床疗效。方法:选取心绞痛患者90例随机平均分为两组,丹参组和消心痛组,治疗3个月。在治疗前、后分别检查两组患者的血脂、血液流变学、心电图并记录其心绞痛情况。结果:两组患者治疗前后心绞痛症状、心电图疗效、血脂相比较无明显差异(P>0.05)。丹参片组治疗前后ηbh、ηbl、ηp均有明显差异(P<0.01,P<0.01,P<0.01)。消心痛组治疗前后ηbh、ηbl有明显差异、ηp有差异(P<0.01,P<0.01,P<0.05),两组治疗前后HCT均有所改善(P<0.05),丹参片组治疗后ηbl降低程度优于消心痛组(P<0.05)。结论:丹参片可用于冠心病心绞痛的长期治疗。 AIM : To observe the therapeutic effect of Lei' s Danshen Tablets (LDT) in treating patients with angina pectoris. METHODS: 90 patients with angina pectoris were divided into two groups randomly. The treated group were treated with LDT and the control group were treated with Isosorbide Dinitrate Tablets for 3 months. We examined their blood lipoid, hemorheology, EKG, recorded the symptoms of angina pectoris before and after this observation. RESULTS: There was no difference between these two groups on blood lipoid, hemorheology, EKG (P 〉 0.05). After the treatment the level of ηbl, ηbh, ηp of treated group degraded obviously (P 〈 0.01, P 〈 0.01, P 〈 0.01 ) the level of ηbl, ηbh of control group also degraded obviously and the level of ηp degraded (P 〈 0.01, P 〈 0.01 ,P 〈 0.05 ). The level of HCT of these two groups also degraded at the end of this observation (P 〈 0.05). After the treatment the level of ηbl of treated group was lower than control group ( P 〈 0.05). CONCLUSION: Leig Danshen Tablet is a kind of medicine for long-term treatment of angina pectoris.
出处 《中成药》 CAS CSCD 北大核心 2005年第8期920-922,共3页 Chinese Traditional Patent Medicine
关键词 丹参片 冠心病心绞痛 Lei's Danshen Tablet (LDT) angina pectoris
  • 相关文献

参考文献3

二级参考文献10

  • 1GibbonsRJ,ChatterjeeK,DaleyJ ,etal.ACC/AHA/ACP ASIMguidelinesforthemanagementofpatientswithchronicstableangina:executivesummaryandrecommendations:areportoftheAmericanCollegeofCardiology/AmericanHeartAssociationTaskForceonPracticeGuidelines(CommitteeonManagementofPatientswithChronicStableAn[].Circulation.1999
  • 2Parker JD,Parker JO.Nitrate therapy for stable angina pectoris[].The New England Journal of Medicine.1998
  • 3Gunasekara NS,Noble S.Isosorbide 5-mononitrate: a review of a sustained-release formulation in stable angina pectoris[].Drugs.1999
  • 4Harrison DG,Bates JN.The nitrovasodilators new ideas about old drugs[].Circulation.1993
  • 5Cheitlin MD,Hutter AM Jr,Brindis RG,et al.Use of sildenafil(Viagra) in patients with cardiovascular disease[].Circulation.1999
  • 6de Milliano PA,Koster RW,Bataimi FW,et al.Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris[].The American Journal of Cardiology.1991
  • 7Parker JO,Fung HL,Ruggirello D,et al.Tolerance to isosorbide dinitrate: rate of development and reversal[].Circulation.1983
  • 8Parker JO,Farrell B,Lahey KA,et al.Effect of intervals between doses on the development of tolerance to isosorbide dinitrate[].The New England Journal of Medicine.1987
  • 9Thadani U,Maranda CR,Amsterdam E,et al.Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate[].Annals of Internal Medicine.1994
  • 10Wisenberg G,Roks C,Nichol P,et al.Sustained effect of and lack of development of tolerance to controlled-release isosorbide-5-mononitrate in chronic stable angina pectoris[].The American Journal of Cardiology.1989

共引文献83

同被引文献81

引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部